Contemporary Management of HIV: New Data From CROI 2019

In these live workshops, expert faculty will review key findings from the Seattle meeting and discuss how they affect optimal management of patients with HIV. 

Agenda

  • Introduction and Program Overview
  • Key Findings From CROI 2019
    • Targeted PrEP
    • Rapid ART Initiation
    • Switching ART in Suppressed Patients
    • Investigational Agents and Strategies
    • ART Use With TB Therapy
    • Chronic Kidney Disease in HIV
    • HIV and Pregnancy
  • Question and Answer Session

Events

Date / Time
Event Details

Faculty

Program Director
Joseph Eron, MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Program Director
Princy Kumar, MD

Professor of Medicine and Microbiology
Chief,
Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Faculty
Roger Bedimo, MD

Professor of Medicine
Division of Infectious Diseases
University of Texas Southwestern Medical Center
Section Chief
Division of Infectious Diseases
Department of Internal Medicine
VA North Texas Health Care System
Dallas, Texas

Faculty
Ian Frank, MD

Professor of Medicine
University of Pennsylvania
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Philadelphia, Pennsylvania

Faculty
Monica Ghandi, MD

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
University of California, San Francisco
Medical Director
Ward 86 HIV Clinic
San Francisco General Hospital
San Francisco, California

Faculty
David Hardy, MD

Adjunct Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland
Senior Director of Evidence-Based Practices
Whitman-Walker Health
Washington, DC

Faculty
Lisa Hightow-Weidman, MD

Professor
Division of Infectious Diseases
Department of Medicine
University of North Carolina, Chapel Hill
Chapel Hill, North Carolina

Faculty
Paul E. Sax, MD

Clinical Director
HIV Program and Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Faculty
Heidi Swygard, MD

Clinical Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Faculty
Timothy Wilkin, MD

Associate Professor of Medicine
Co-Director, Cornell Clinical Trials Unit
Weill Cornell Medical College
New York, New York

Goal Statement
The goal of this activity is to improve participants’ competence in providing optimal care for HIV-infected patients through the appropriate use of contemporary ARV regimens.

Target Audience 
This program is intended for physicians, registered nurses, physician assistants, pharmacists, and other healthcare professionals who provide care for HIV-infected patients.

Learning Objectives 

  • Appropriately counsel patients regarding data from clinical trials evaluating the use of antiretroviral agents to prevent HIV infection
  • Incorporate the results of recent clinical studies when utilizing antiretroviral agents for individualized management of HIV infection
  • Provide insightful counsel to patients and colleagues regarding studies of investigational antiretroviral agents and strategies in advanced stages of development

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation
CCO designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this activity is 2.5 contact hours.

Pharmacy Continuing Education
CCO designates this continuing education activity for 2.5 contact hours (0.25 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-19-006-L02-P.

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.